ENDRA Life Sciences
NDRA
2 hedge funds and large institutions have $323K invested in ENDRA Life Sciences in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
69% more capital invested
Capital invested by funds: $191K → $323K (+$132K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
+$243K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SWM
1
SeaCrest Wealth Management
Purchase,
New York
| $234K | +$243K | +3 | New |
|
|
WEC
2
Winslow Evans & Crocker
Boston,
Massachusetts
| $52K | – | – | – |
|
|
IFAM
3
Institutional & Family Asset Management
Fort Collins,
Colorado
| $25K | – | – | – |
|
|
FIA
4
FNY Investment Advisers
New York
| $12K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$40K | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$6K | – | – |
|
NDRA Hedge Fund Activity: Q2 2018 in Review
2 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2018, worth a combined $323K — up 69% from $191K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NDRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SeaCrest Wealth Management, opening a new position worth an estimated $243K. The largest seller was Susquehanna International Group, cutting an estimated $40K.
- 2 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $323K of ENDRA Life Sciences stock for Q2 2018, up 69% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q2 2018 was SeaCrest Wealth Management, an estimated $243K added.
- The largest ENDRA Life Sciences seller in Q2 2018 was Susquehanna International Group, an estimated $40K sold.
Based on aggregated 13F filings for Q2 2018.